Physician
Salimi-Tari, Peyman
Salimi-Tari, Peyman was paid $183K by Medicaid between Jan 2018 and Aug 2023, across 7 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 80% of everything it billed.
33Billing provider infoSALIMI-TARI, PEYMAN
FOUNTAIN VALLEY, CA 92708
FOUNTAIN VALLEY, CA 92708
33aNPI1639238371assigned 12/08/2006
33bProvider typeHematology & Oncology Physician
28Total paid$183K
24GClaims3,509
24DCodes billed7
24AFirst – last monthJan 2018 – Aug 2023
Compared with peers
Next to other Hematology & Oncology Physician providers in California
Rank by total paid#36 of 180
Median peer was paid$26K
This provider vs. median7.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 478 | $32K | |
| 2019 | 1,015 | $53K | |
| 2020 | 520 | $35K | |
| 2021 | 576 | $22K | |
| 2022 | 635 | $21K | |
| 2023 | 285 | $20K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 80% | 2,292 | 1,557 | $147K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 668 | 564 | $24K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 6.3% | 392 | 238 | $12K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 69 | 36 | $369.12 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 49 | 24 | $311.20 |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 12 | 12 | $237.60 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 27 | 12 | $208.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.